Site Home

Department of General Medicine

RCH > Medicine > General Medicine

 

RCH Immunisation Service

BORDER GRAPHICS2.jpgﾠ

Current Immunisation Schedule (from 1 March 2008)

Age of Child
Birth HepB
2 months

DTPa-hepB-IPV-Hib
(Infanrix-Hexa)

Oral Rotavirus

(Rotateq)

Pneumococcal

(Prevenar)
4 months

DTPa-hepB-IPV-Hib
(Infanrix-Hexa)

Oral Rotavirus

(Rotateq)

Pneumococcal

(Prevenar)
6 months DTPa-hepB-IPV-Hib
(Infanrix-Hexa)

Oral Rotavirus

(Rotateq)

Pneumococcal

(Prevenar)

7
12 months Hib 
(Hiberix)
 1

 

MMR

(Priorix)

Meningo C 2

(NeisVacC)
18 months

Varicella 3

(Varilrix)
4 years

DTPa-IPV

(Infanrix-IPV)

MMR

(Priorix)
Year 7

HPV 6

(Gardasil)

 HepB 5

Varicella 4

(Varilrix)
Year 10

dTpa

(Boostrix)

 
  1. Premature infants < 32 weeks require an additional Hep B booster dose of vaccine at 12 months
  2. Meningococcal C vaccine can be given < 1 yr but is not currently funded (2 - 6 months 3 doses; 6-12 months 2 doses).
  3. Varicella vaccine is funded for infants aged 18 months. It can be given at 12 months of age on the same day as MMR vaccine or 4 weeks later.
  4. A catch-up dose of varicella vaccine is given to students in Year 7 who have not had chickenpox or varicella vaccine.
  5. Adolescents aged 11-15 years who have not previously had hepatitis B vaccine are given 2 doses 4 - 6 months apart (using adult formulation).
  6. HPV vaccine is funded for all girls aged 12 - 26 years until the end of June 2009.  The funding will then be ongoing for all girls in Year 7.  Following the 1st dose, the 2nd dose is given 1-2 months after 1st dose; 3rd dose is given 3-4 months after 2nd dose.
  7. Influenza vaccine can be given to any infant > 6 months. Children in certain risk groups are highly recommended annual influenza vaccine. Children < 9 years require 2 doses in the first year they receive the vaccine. The dose for children aged 6 months - 2 years is 0.25ml; >3 years the dose is 0.5ml.  

^ Back to schedule

See also

ﾠ

The National Immunisation Program Schedule provides free oral Rotavirus vaccine to infants aged two, four and six months of age. The first dose of Rotateq should be given no later than 12 weeks of age and the third dose should be given by 32 weeks of age. Please contact the Immunisation service with any queries regarding the Rotavirus vaccine.

The Human Papilloma Virus (HPV) Gardasil vaccine is registered for boys aged 9-15 years and girls aged 9-26 years. There is no current funding for boys and from April 2007 the Australian Government is funding the Gardasilﾮ vaccine for girls and women aged 12-26 years. The following age categories will be targeted from April 2007;

  • 12-13 years as part of a Year 7 secondary school program (which will be ongoing)
  • 13-18 years (catch-up secondary school immunisation program, funded for 2 years)
  • 18-26 years (catch-up funded for 2 years)

Cervarix is a HPV vaccine registered, but not funded for females from 10 to 45 years of age to prevent early stage cervical cancer caused by HPV types 16 and 18. There is no external genital wart protection with this vaccine unlike Gardasil, which includes HPV types 16, 18 and also types 6 and 11.

 

For general immunisation inquiries - please ring 9345 6599.  The Immunisation centre is located on the first floor near the blue lifts and is available Monday to Friday 9am - 5pm for advice and follow-up of immunisation issues as well as vaccinations.  No appointment necessary.

They contain a number of resources that the Immunisation service provides to clinicians at the Royal Children's Hospital. Please contact Dr Jenny Royle, or Sonja Eliaif you have any suggestions for improvements to these pages

 

Last Updated 30-Aug-2009. Authorised by: Mike South. Enquiries: Mike South.
webmaster. © RCH.